Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients

Background: The study aimed to evaluate the appropriate uptake-timing in cognitively normal individuals, mild cognitive impairment (MCI), and Alzheimer’s disease (AD) patients, using 18 F-PI 2620 dynamic PET acquisition. Methods: Thirty-four MCI patients, 6 AD patients, and 24 cognitively normal ind...

Full description

Saved in:
Bibliographic Details
Main Authors: Chanisa Chotipanich, Monchaya Nivorn, Anchisa Kunawudhi, Chetsadaporn Promteangtrong, Natphimol Boonkawin, Attapon Jantarato
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1177/1536012120947582
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564472503697408
author Chanisa Chotipanich
Monchaya Nivorn
Anchisa Kunawudhi
Chetsadaporn Promteangtrong
Natphimol Boonkawin
Attapon Jantarato
author_facet Chanisa Chotipanich
Monchaya Nivorn
Anchisa Kunawudhi
Chetsadaporn Promteangtrong
Natphimol Boonkawin
Attapon Jantarato
author_sort Chanisa Chotipanich
collection DOAJ
description Background: The study aimed to evaluate the appropriate uptake-timing in cognitively normal individuals, mild cognitive impairment (MCI), and Alzheimer’s disease (AD) patients, using 18 F-PI 2620 dynamic PET acquisition. Methods: Thirty-four MCI patients, 6 AD patients, and 24 cognitively normal individuals were enrolled in this study. A dynamic 18 F-PI 2620 PET study was conducted at 30-75 minutes post-injection in these groups. Co-registration was applied between the dynamic acquisition PET and T1-weighted MRI to delineate various cortical regions. The standardized uptake value ratio (SUVR) was used for quantitative analysis. P-mod software with the Automated Anatomical Labeling (AAL)-merged atlas was employed to generate automatic volumes of interest for 11 brain regions. Results: The curves in most brain regions presented an average SUVR stability at 30-40 minutes post-injection in each group. The appropriate uptake-timing interval of 18 F-PI 2620 was 30-75 minutes post injection for AD group and 30-40 minutes post injection for both cognitively normal individuals and MCI groups. Conclusion: Short uptake time around 30-40 minutes post-injection would be more comfortable and convenient for all patients, especially in those with dementia who were unable to stay motionless for long periods of scanning time in the scanner.
format Article
id doaj-art-875e72a966ab48c09a80a8cd4f418507
institution Kabale University
issn 1536-0121
language English
publishDate 2020-08-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-875e72a966ab48c09a80a8cd4f4185072025-01-02T22:38:22ZengSAGE PublishingMolecular Imaging1536-01212020-08-011910.1177/1536012120947582Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease PatientsChanisa Chotipanich0Monchaya Nivorn1Anchisa Kunawudhi2Chetsadaporn Promteangtrong3Natphimol Boonkawin4Attapon Jantarato5 National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, ThailandBackground: The study aimed to evaluate the appropriate uptake-timing in cognitively normal individuals, mild cognitive impairment (MCI), and Alzheimer’s disease (AD) patients, using 18 F-PI 2620 dynamic PET acquisition. Methods: Thirty-four MCI patients, 6 AD patients, and 24 cognitively normal individuals were enrolled in this study. A dynamic 18 F-PI 2620 PET study was conducted at 30-75 minutes post-injection in these groups. Co-registration was applied between the dynamic acquisition PET and T1-weighted MRI to delineate various cortical regions. The standardized uptake value ratio (SUVR) was used for quantitative analysis. P-mod software with the Automated Anatomical Labeling (AAL)-merged atlas was employed to generate automatic volumes of interest for 11 brain regions. Results: The curves in most brain regions presented an average SUVR stability at 30-40 minutes post-injection in each group. The appropriate uptake-timing interval of 18 F-PI 2620 was 30-75 minutes post injection for AD group and 30-40 minutes post injection for both cognitively normal individuals and MCI groups. Conclusion: Short uptake time around 30-40 minutes post-injection would be more comfortable and convenient for all patients, especially in those with dementia who were unable to stay motionless for long periods of scanning time in the scanner.https://doi.org/10.1177/1536012120947582
spellingShingle Chanisa Chotipanich
Monchaya Nivorn
Anchisa Kunawudhi
Chetsadaporn Promteangtrong
Natphimol Boonkawin
Attapon Jantarato
Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
Molecular Imaging
title Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
title_full Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
title_fullStr Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
title_full_unstemmed Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
title_short Evaluation of Imaging Windows for Tau PET Imaging Using F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
title_sort evaluation of imaging windows for tau pet imaging using f pi2620 in cognitively normal individuals mild cognitive impairment and alzheimer s disease patients
url https://doi.org/10.1177/1536012120947582
work_keys_str_mv AT chanisachotipanich evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients
AT monchayanivorn evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients
AT anchisakunawudhi evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients
AT chetsadapornpromteangtrong evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients
AT natphimolboonkawin evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients
AT attaponjantarato evaluationofimagingwindowsfortaupetimagingusingfpi2620incognitivelynormalindividualsmildcognitiveimpairmentandalzheimersdiseasepatients